Macrocyclic complexes of technetium-99m for use as diagnostic ra

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 9, 534 14, A61K 4300, A61K 4900

Patent

active

046158766

ABSTRACT:
Stable neutral-lipophilic complexes of technetium-99m (Tc-99m) useful as diagnostic radionuclidic imaging agents are formed by complexing technetium-99m pertechnetate with alkylene amine oximes (viz. propylene amine oxime) in aqueous solutions under reducing conditions. The complexes have a zero charge, contain an O--H--O ring closure bond, and are sufficiently stable for parental administration in imaging by scintillation scanning. Substituents can be attached to the C.sub.2 to C.sub.4 alkylene carbon backbone of the tetradentate amine oxime ligands to structurally modify them and produce a variety of Tc-99m-radiopharmaceuticals with specific body imaging applications.

REFERENCES:
patent: 4352751 (1982-10-01), Wieder et al.
patent: 4360511 (1982-11-01), Baldwin et al.
patent: 4363793 (1982-12-01), Blau et al.
Karesh et al, J. Pharmaceutical Sciences, 66 (1977) 225-8.
Eckelman et al. J. Pharmaceutical Sciences, 64 (1975) 704-6.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Macrocyclic complexes of technetium-99m for use as diagnostic ra does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Macrocyclic complexes of technetium-99m for use as diagnostic ra, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrocyclic complexes of technetium-99m for use as diagnostic ra will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-642365

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.